Does DABRAFENIB Cause Interstitial lung disease? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Interstitial lung disease have been filed in association with DABRAFENIB (Tafinlar). This represents 0.4% of all adverse event reports for DABRAFENIB.
84
Reports of Interstitial lung disease with DABRAFENIB
0.4%
of all DABRAFENIB reports
15
Deaths
23
Hospitalizations
How Dangerous Is Interstitial lung disease From DABRAFENIB?
Of the 84 reports, 15 (17.9%) resulted in death, 23 (27.4%) required hospitalization, and 3 (3.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for DABRAFENIB.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DABRAFENIB Alternatives Have Lower Interstitial lung disease Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB